(Q40568074)

21 September 2017

title

Combined two-dose hepatitis A and B vaccine (AmBirix). (English)

1 reference

21 September 2017

1 reference

2

David P Figgitt

1 reference

21 September 2017

Blair Jarvis

1

1 reference

21 September 2017

publication date

1 January 2003

1 reference

21 September 2017

1 reference

21 September 2017

volume

63

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

207-13; discussion 214-5

1 reference

Consensus statements on the prevention and management of hepatitis B and hepatitis C in the Asia-Pacific region. Core Working Party for Asia-Pacific Consensus on Hepatitis B and C

21 September 2017

cites work

1 reference

12 December 2020

Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001.

1 reference

12 December 2020

Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study

1 reference

12 December 2020

Hepatitis A shifting epidemiology in Latin America

1 reference

12 December 2020

Integration of hepatitis B vaccination into national immunisation programmes. Viral Hepatitis Prevention Board

1 reference

12 December 2020

Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults

1 reference

12 December 2020

Vaccination of travelers against hepatitis A and B.

1 reference

12 December 2020

The case for routine childhood vaccination against hepatitis A

1 reference

12 December 2020

Long term (24 months) follow-up of a hepatitis A and B vaccine, comparing a two and three dose schedule in adolescents aged 12-15 years

1 reference

12 December 2020

From the Centers for Disease Control and Prevention. Update: recommendations to prevent hepatitis B virus transmission--United States

1 reference

12 December 2020

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

1 reference

12 December 2020

Update on diagnosis, management, and prevention of hepatitis B virus infection

1 reference

12 December 2020

Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls

1 reference

12 December 2020

Vaccines to prevent viral hepatitis

1 reference

12 December 2020

A two dose schedule for combined hepatitis A and hepatitis B vaccination in children ages one to eleven years

1 reference

12 December 2020

Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan

1 reference

12 December 2020

Should adolescents be vaccinated against hepatitis A: the Hong Kong experience

1 reference

12 December 2020

10.2165/00003495-200363020-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

21 September 2017

1032827382

0 references

1 reference